Purchases and Sales Made in Q2 2023 in Catalyst Pharmaceuticals, Inc. (CPRX)
This table provides information about the institutional ownership of Catalyst Pharmaceuticals, Inc. (CPRX) during Q2 2023. The information is specifically focused on institutions that hold shares of CATALYST PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-534K- 37.4% |
$6.14M - $9.66M
|
894K
$18.4M
|
|
|
Aug 14, 2023
Q2 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-804K- 68.15% |
$9.24M - $14.5M
|
376K
$7.74M
|
|
|
Aug 10, 2023
Q2 2023
|
Jupiter Asset Management LTD
|
SELL
|
- |
-877K- 61.59% |
$10.1M - $15.9M
|
547K
$11.3M
|
|
|
Aug 14, 2023
Q2 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-944K- 59.85% |
$10.9M - $17.1M
|
633K
$13M
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.04M- 76.75% |
$12M - $18.8M
|
315K
$6.49M
|
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-1.16M- 97.86% |
$13.3M - $21M
|
25.4K
$523K
|
|
|
Aug 14, 2023
Q2 2023
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-2.16M- 20.89% |
$24.9M - $39.1M
|
8.19M
$169M
|